The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.

Erdem, Selçuk; Yegen, Gülçin; Telci, Dilek; Yildiz, Ibrahim; Tefik, Tzevat; Issever, Halim; Kilicaslan, Isin; Sanli, Mehmet

doi:10.1007/s00345-014-1462-7

The increased transglutaminase 2 expression levels during initial tumorigenesis predict increased risk of metastasis and decreased disease-free and cancer-specific survivals in renal cell carcinoma.

Atıf İçin Kopyala

Erdem S., Yegen G., Telci D., Yildiz I., Tefik T., Issever H., ...Daha Fazla

World journal of urology, cilt.33, sa.10, ss.1553-60, 2015 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 33 Sayı: 10
Basım Tarihi: 2015
Doi Numarası: 10.1007/s00345-014-1462-7
Dergi Adı: World journal of urology
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1553-60
Anahtar Kelimeler: Renal cell carcinoma, Transglutaminase 2, Tumor marker, Metastasis, TISSUE TRANSGLUTAMINASE, ADHESION
İstanbul Üniversitesi Adresli: Evet

Özet

The aim of this study was to investigate the role of transglutaminase 2(TG2) in renal cell carcinoma (RCC) by comparing the immunohistochemistry staining of primary and metastatic tumor tissues.